News | March 13, 2015

Infraredx Launches Advanced TVC Imaging System, Muller NIRS-IVUS Catheter at ACC 2015

System’s Extended Bandwidth IVUS technology sharpens images for easy identification

Infraredx, NIRS, IVUS, catheter, Advanced TVC Imaging System, ACC 15

March 13, 2015 — Infraredx announced it will premiere the Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter featuring Extended Bandwidth IVUS technology at the American College of Cardiology’s 2015 Annual Scientific Meeting in San Diego, March 14-16.

The Advanced TVC Imaging System is a U.S. Food and Drug Administration (FDA)-cleared technology capable of rapidly, specifically and reliably identifying lipid-core plaques (LCPs), which are known to complicate stenting procedures and suspected to cause most heart attacks.

By integrating near-infrared spectroscopy (NIRS) with intravascular ultrasound (IVUS), the Advanced TVC Imaging System enables quick, informed clinical decision-making and greater physician confidence in determining procedural and treatment strategies requiring information on vessel structure and plaque composition. This high-powered platform is designed to evolve with coronary care and incorporates advanced computing technology; high-definition monitors; an intuitive, user-friendly interface; and near-infrared laser optics for in vivo chemical analysis.

The system also includes Infraredx’s proprietary Extended Bandwidth IVUS technology, which harmonizes multiple signal frequencies to produce a sharp image of the complete vessel that allows for easy identification of the lumen, plaque and vessel structure.

In addition, a meeting of the Lipid-rich Plaque Study investigators will be held. This multicenter study is designed to test the hypothesis that true vessel characterization (TVC) imaging can identify the plaques likely to cause a heart attack. The study already has more 850 patients enrolled and is expected to yield a result in late 2015.

For more information: www.infraredx.com

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init